Immune Tolerance and Inflammation in ABPA in Patients with Cystic Fibrosis
囊性纤维化患者 ABPA 的免疫耐受和炎症
基本信息
- 批准号:8118860
- 负责人:
- 金额:$ 51.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffectAllergicAllergic Bronchopulmonary AspergillosisAllergic DiseaseAntibodiesAntigen-Presenting CellsAntigensAspergillusAspergillus fumigatusAsthmaAzolesBindingBiological AssayBloodBronchiectasisCD4 Positive T LymphocytesCaspofunginCell Culture SystemCellsCoculture TechniquesCystic FibrosisDataDendritic CellsDevelopmentDiagnosisFibrosisFlow CytometryFoxesGenerationsGlucansHigh PrevalenceHypersensitivityIL2RA geneIgEImmune ToleranceIndividualInflammationInflammatoryInflammatory ResponseInterleukin-10Interleukin-13Interleukin-4Interleukin-5KnowledgeLaboratoriesLigandsLigaseLungLung diseasesMediatingMicroscopyModelingMusOrganismPatientsPhenotypePlayPopulationProductionRegulatory T-LymphocyteRoleSputumStimulusSurfaceSwellingT cell responseT-LymphocyteTestingTimeUniversitiesVoriconazoleWheezingWorkadaptive immunityatopybasebeta-1,3-glucanbeta-Glucansbeta-glucan receptorcystic fibrosis patientscytokinedectin 1human subjectinhibitor/antagonistmacrophagemonocyteneutralizing antibodyneutrophilperipheral bloodreceptorresponse
项目摘要
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic disease characterized clinically by wheezing,
pulmonary infiltrates, bronchiectasis, and fibrosis that affects patients with asthma and cystic fibrosis (CF). In
patients with ABPA, immunological responses to a variety of Aspergillus fumigatus (Af) antigens result in a
heightened Th2 response and an elevated immunoglobulin E (IgE) level. At our CF Center ABPA affects 7%
of the CF population however over 30% are colonized with Af. Preliminary data in our laboratory
demonstrates that Dectin-1, a beta-glucan receptor expressed in dendritic cells and macrophages is required
for recognition of swollen conidia; a form of Af that precedes hyphal development. Preliminary data suggest
that Dectin-1 is also required for Th2 response in CF patients with ABPA. Additionally patients with Af
colonization without ABPA have elevated antigen specific IL-10 responses which we propose is due the
development of regulatory T-cell response in these patients. Based on these data, we hypothesize that CF
patients with ABPA require monocyte/dendritic cell expression of dectin-1 for the presentation of specific
Aspergillus antigens (namely swollen conidia) as well as for Th2 cytokine elaboration. Moreover, we
hypothesize that a decreased in Treg cells is required for development of APBPA compared to CF patients
colonized with Aspergillus but no evidence of ABPA. To test these hypotheses, we propose the following
specific aims: Specific Aim 1: To test the hypothesis that CF patients with ABPA require Dectin-1 expression
on peripheral blood monocytes/dendritic cells and that binding of A. fumigatus to Dectin-1 will produce a
heightened inflammatory response in patients with ABPA compared to non-ABPA patients. Specific Aim 2:
To test the hypothesis that T cells from CF patients with ABPA will have decreased adaptive Treg function.
Specific Aim 3. To test the hypothesis that anti-fungals targeted against glucan synthetase block both proinflammatory
and Th2 cytokine induction in peripheral blood of patients with CF with ABPA. Understanding
these responses in ABPA will increase our knowledge regarding mechanisms of allergy vs. tolerance in
human subjects.
过敏性支气管肺曲霉病(ABPA)是一种以喘息为临床特征的变应性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAY K KOLLS其他文献
JAY K KOLLS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAY K KOLLS', 18)}}的其他基金
Generation of Novel Human Monoclonals for Lung Disease
用于肺部疾病的新型人单克隆抗体的产生
- 批准号:
9250044 - 财政年份:2016
- 资助金额:
$ 51.6万 - 项目类别:
相似海外基金
Is sialic acid recognition receptor a candidate molecule for diagnosis of allergic bronchopulmonary aspergillosis?
唾液酸识别受体是诊断过敏性支气管肺曲霉病的候选分子吗?
- 批准号:
20K07183 - 财政年份:2020
- 资助金额:
$ 51.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of new experimental models to understand the genetic basis of allergic bronchopulmonary aspergillosis (ABPA)
开发新的实验模型以了解过敏性支气管肺曲霉病(ABPA)的遗传基础
- 批准号:
NC/P002390/1 - 财政年份:2017
- 资助金额:
$ 51.6万 - 项目类别:
Fellowship
Airway inflamation in allergic bronchopulmonary aspergillosis and the use of Itraconazole
过敏性支气管肺曲霉病的气道炎症和伊曲康唑的使用
- 批准号:
nhmrc : 8201 - 财政年份:2000
- 资助金额:
$ 51.6万 - 项目类别:
NHMRC Postgraduate Scholarships
AEROSOL ANTIGEN CHALLENGE IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
过敏性支气管肺曲霉病中的气溶胶抗原挑战
- 批准号:
4701085 - 财政年份:
- 资助金额:
$ 51.6万 - 项目类别:
AEROSOL ANTIGEN CHALLENGE IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
过敏性支气管肺曲霉病中的气溶胶抗原挑战
- 批准号:
3973552 - 财政年份:
- 资助金额:
$ 51.6万 - 项目类别: